Topical Pilocarpine Formulations for Skin Conditions

The inventive concept relates to the application of stable pilocarpine formulations, originally developed for ophthalmic conditions, to treat various skin conditions, leveraging the compound's pharmacological properties to provide effective solutions.

The original patent disclosed stable pilocarpine formulations for treating ophthalmic conditions, primarily presbyopia. However, there exists a need for effective treatments for various skin conditions, such as acne, fungal infections, and rosacea, which share similar underlying physiological mechanisms with presbyopia. The inventive concept addresses this limitation by adapting the core technology to develop topical pilocarpine formulations for skin conditions.

The new inventive concept involves the development of reduced buffer content compositions comprising an effective amount of a pilocarpine compound, tailored for topical application to the skin. These compositions maintain a pH of between about 3 and about 6 and at least about 97% of the pilocarpine compound originally present in the composition when stored under conditions comprising a temperature of about 25°C±2°C and a relative humidity of about 60%±5%. The pilocarpine compound can be used in combination with other active agents, such as antifungal agents or vasoconstrictors, to enhance its therapeutic effects. The compositions can be administered via various routes, including transdermal patches or direct application to the affected skin area.

The new inventive concept is novel and non-obvious as it applies the core technology of the original patent to a completely new field, leveraging the pharmacological properties of pilocarpine to address unmet needs in skin condition treatments. The inventive step lies in the adaptation of the stable pilocarpine formulations for topical application, which requires careful consideration of skin physiology and the development of new compositions and delivery systems.

Alternative embodiments of the inventive concept could include the use of different pilocarpine salts, varying the concentration of the pilocarpine compound, or incorporating additional active agents to enhance the therapeutic effects. The compositions could also be adapted for use in other dermatological conditions, such as psoriasis or eczema.

The inventive concept has significant commercial potential in the dermatology market, which is projected to grow substantially in the coming years. The topical pilocarpine formulations could be marketed as prescription or over-the-counter products, offering a new treatment option for patients suffering from various skin conditions. The target industries include pharmaceutical companies, dermatology clinics, and skincare product manufacturers.